Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Changes in normal appearing spinal cord in multiple sclerosis: another brick in the wall.
Acute disseminated encephalomyelitis following inactivated influenza vaccination in the Brazilian Amazon: a case report.
InMS: Chronic insomnia disorder in multiple sclerosis - a Portuguese multicentre study on prevalence, subtypes, associated factors and impact on quality of life.
Newer therapies for multiple sclerosis.
Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response.
Specificities of children with multiple sclerosis and neuromyelitis optica.
Label-free imaging to study phenotypic behavioural traits of cells in complex co-cultures.
Design, Synthesis, and Evaluation of Fluorinated Radioligands for Myelin Imaging.
Is there A Genetic Correlation between Multiple Sclerosis and Cerebral Aneurysms?
MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patients.
Harnessing the integrated stress response for the treatment of multiple sclerosis.
Factors Related to Social Support in Neurological and Mental Disorders.
A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia.
Evaluating the Effects of White Matter Multiple Sclerosis Lesions on the Volume Estimation of 6 Brain Tissue Segmentation Methods.
Cardiovascular effects of fingolimod: Relevance, detection and approach.
Experimental autoimmune encephalomyelitis.
[Association between Multiple Sclerosis or Neuromyelitis Optica and Epstein-Barr Virus].
Alteration of delta-6-desaturase (FADS2), secretory phospholipase-A2 (sPLA2) enzymes by Hot-nature diet with co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.
Pharmacology and Structure of P2Y Receptors.
Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset.
[Oral disease-modifying agents in relapsing-remitting multiple sclerosis].
An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis.
Aging with multiple sclerosis: cognitive, emotional and neuropathological considerations.
Multiple sclerosis incidence associated with the soil lead and arsenic concentrations in taiwan.
The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells.
Pages
« first
‹ previous
…
657
658
659
660
661
662
663
664
665
…
next ›
last »